Lab & Pathology Merger & Acquisitions: Business Opportunities in Molecular Diagnostics and Genetic Testing for Lab Owners and Investors

Tuesday, April 30th, 20191:30 PM - 4:35 PM

“Threats and Opportunities for Hospital and Health Network Laboratories”
“What Lab Buyers See as Opportunity in Today’s Market: Clinical Labs, Hospital Lab Outreach Businesses, Pathology Groups, and Molecular/Genetic Lab Companies”
“Anatomic Pathology Groups and Their Labs: Effective Strategies for Maintaining Clinical Excellence and Financial Stability During Disruptive Times”
“Strategies for Molecular/Genetic Labs to Improve Collected Revenue, Survive Tougher Audits, and Build Capital Value for Shareholders”


James Almas

James P. Almas

Vice President and National Medical Director of Clinical EffectivenessLabCorpBurlington, NC
Al Sirmon

Al Sirmon

ConsultantPathology Practice Advisors, LLCPawleys Island, SC
Raymond Kelly

Raymond Kelly

Director of Corporate DevelopmentEurofins Scientific GroupHorsham, PA